Perthera, Inc

Perthera guides advanced-stage cancer patients and their physicians to the best-personalized cancer treatment options available by bridging the gap between molecular testing and patient therapy.

Our unique approach uses the most advanced molecular diagnostic testing to create a detailed analysis of a patient's unique cancer. Perthera's proprietary Therapeutic Intelligence Engine combines molecular analysis with the patient's medical history and generates a comprehensive report, which is reviewed by an expert virtual molecular tumor board.